Could weight-loss drugs eat the world?
Scientists are finding that anti-obesity medicines can also help many other diseases
The Gila monster is a poisonous North American lizard that measures around 50 centimetres and sports a distinctive coat of black and orange scales. This lethargic reptile, which mostly dwells underground and eats just three to four times a year, is the unlikely inspiration for one of pharma’s biggest blockbusters: a new generation of weight-loss drugs that has patients—and investors—in a frenzy. Originally made for diabetes, evidence is growing that they also have benefits in diseases of the heart, kidney, liver and beyond.
This article appeared in the Science & technology section of the print edition under the headline “Eating the world”
From the April 6th 2024 edition
Discover stories from this section and more in the list of contents
Explore the editionDiscover more
Deforestation is costing Brazilian farmers millions
Without trees to circulate moisture, the land is getting hotter and drier
Robots can learn new actions faster thanks to AI techniques
They could soon show their moves in settings from car factories to care homes
Scientists are learning why ultra-processed foods are bad for you
A mystery is finally being solved
Scientific publishers are producing more papers than ever
Concerns about some of their business models are building
The two types of human laugh
One is caused by tickling; the other by everything else
Scientists are building a catalogue of every type of cell in our bodies
It has thus far shed light on everything from organ formation to the causes of inflammation